For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are ...
Early-stage trials of a new drug for advanced prostate cancer have yielded "remarkable" results, according to medical experts. This innovative treatment, an immunotherapy designed to harness the ...
An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...
Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on ...
The data were presented at the American Urological Association (AUA) 2026 Annual Meeting. ・Candel plans to submit a Biologics ...
A new experimental drug is showing potential in treating prostate cancer and possibly other forms of the disease. A new immunotherapy drug used in a prostate cancer clinical trial is showing early ...
Alembic Pharma received USFDA tentative approval for Darolutamide 300 mg generic tablets used in prostate cancer, targeting a ...
The Oncologic Drugs Advisory Committee backed the prostate cancer drug but rejected a novel approach for breast cancer, highlighting challenges in defining clinical meaningfulness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results